Community‐Sourced Reporting of Mortalities in Angelman Syndrome (1979–2022)

Angelman syndrome (AS) is a severe genetic neurodevelopmental disorder with an estimated prevalence of 1:20,000. Life expectancy appears to be normal, however, data regarding lifespan in AS are scarce. Until 2018, there was no unique diagnosis code for AS, thus true incidence, prevalence, mortality and morbidity rates are unknown. A social media effort was launched by caregivers of people with AS to gather community-sourced data to understand AS mortality risks. Information on 220 deaths was verified with obituaries and public postings. Respiratory illness was the primary cause of death among people with AS overall, followed by accidents and seizures. Surprisingly, sudden unexpected death in sleep (SUDS) was the fourth most common cause, which has not been reported previously. Approximately 91% of people with AS have epilepsy, thus some SUDS cases may represent sudden unexpected deaths in epilepsy (SUDEP). Causes of death vary by age, and differ from the general population. Though there are obvious limitations to data collected through social media, grass roots science is a starting point to amass preliminary data and inform future epidemiological research on AS.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2024-12-16
DOI
https://doi.org/10.1002/ajmg.a.63961
Citations
2
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
1.10

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Community‐Sourced Reporting of Mortalities in Angelman Syndrome (1979–2022)

M. Sampedro, Lynne M. Bird, Terry Jo Bichell, Wen‐Hann Tan et al.
2 citations
American Journal of Medical Genetics Part A
Genetic Syndromes and Imprinting
1.10
article

Community‐Sourced Reporting of Mortalities in Angelman Syndrome (1979–2022)

M. Sampedro, Lynne M. Bird, Terry Jo Bichell, Wen‐Hann Tan, Rachel Martin, Sébastien Dubé, Anne Wheeler, K Schmidt David, Adriana Dias Gomes, Meagan Cross, Amanda Moore, Ursula Christel, Cristy Hardesty, Sharon Weil‐Chalker, Adela Gentil Montepagano
article en
2 citations

Abstract

Angelman syndrome (AS) is a severe genetic neurodevelopmental disorder with an estimated prevalence of 1:20,000. Life expectancy appears to be normal, however, data regarding lifespan in AS are scarce. Until 2018, there was no unique diagnosis code for AS, thus true incidence, prevalence, mortality and morbidity rates are unknown. A social media effort was launched by caregivers of people with AS to gather community-sourced data to understand AS mortality risks. Information on 220 deaths was verified with obituaries and public postings. Respiratory illness was the primary cause of death among people with AS overall, followed by accidents and seizures. Surprisingly, sudden unexpected death in sleep (SUDS) was the fourth most common cause, which has not been reported previously. Approximately 91% of people with AS have epilepsy, thus some SUDS cases may represent sudden unexpected deaths in epilepsy (SUDEP). Causes of death vary by age, and differ from the general population. Though there are obvious limitations to data collected through social media, grass roots science is a starting point to amass preliminary data and inform future epidemiological research on AS.

American Journal of Medical Genetics Part AVol. 197(4)
Boston Children's Hospital (US), RTI International (US), Pierre Elliott Trudeau Foundation (CA), University of California San Diego (US), Rady Children's Hospital-San Diego (US), Foundation for Angelman Syndrome Therapeutics (AU), Rome Foundation (US), Boston Children's Museum (US), Patient Advocate Foundation (US), University of Almería (ES)
Ultragenyx Pharmaceutical, Ionis Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 18%
Genetic Syndromes and Imprinting
1.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.